Error: Could not add to watchlist. X

BB Adamant Global Generika

+ Watchlist
ADAGGRA:SW
1,721.84
CHF
39.67
2.36%
As of 12:16:00 ET on 07/01/2015.
Volume
0
Previous Close
1,682.17
52Wk Range
1,361.48 - 1,827.08
1 Yr Return
22.20%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/01/2015)
1,721.84
Total Assets (m CHF) (on 07/01/2015)
196.300
Inception Date
03/03/2008
Last Dividend (on 12/05/2012)
1.6
Dividend Indicated Gross Yield
-
Fund Managers
OLIVER KUBLI
Front Load Fee
2.50%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.81%
Expense Ratio
1.83%
Top Fund Holdings
Name Position Value % of Fund
Allergan plc 33.50 k 9.25 m 4.69
Mallinckrodt PLC 80.00 k 8.85 m 4.49
Akorn Inc 150.00 k 7.65 m 3.88
Shire PLC 90.00 k 6.96 m 3.53
Celltrion Inc 116.37 k 6.59 m 3.34
Jazz Pharmaceuticals PLC 40.00 k 6.45 m 3.27
Shanghai Fosun Pharmaceutical 2.00 m 6.31 m 3.20
ACADIA Pharmaceuticals Inc 170.00 k 6.12 m 3.10
Kalbe Farma Tbk PT 45.00 m 5.93 m 3.01
Lonza Group AG 50.00 k 5.88 m 2.98
Profile
BB Adamant Global Generika Fund is an open-ended investment company incorporated in Switzerland. The Fund's aim is to generate long-term capital growth through active management by investing in companies within the generic sector. The Fund's portfolio will be concentarted to around 30 to 50 stocks which fully meet Adamant's strict selection criteria.
ADDRESS
Balfidor Fondsleitung AG
Peter-Merian Strasse 47
CH 4002 Basel
Switzerland
PHONE
+41 800 850 050